| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | QS11 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.5 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.5 |